Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dominari Holdings | NASDAQ | Financial | Investment Banking & Investment Services | 255.2% | US$59.20M | -1.1x | -0.19 | US$4.13 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intrusion | NASDAQ | Technology | Software & IT Services | 234.3% | US$23.02M | -0.8x | -0.03 | US$1.19 | -7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ibio | NASDAQ | Healthcare | Biotechnology & Medical Research | 96.2% | US$45.72M | -1.7x | -0.04 | US$4.63 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Axim Biotech | OTC Markets | Healthcare | Biotechnology & Medical Research | 66.7% | US$938.69K | -0.6x | -0.01 | US$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ESGL Holdings | NASDAQ | Industrials | Professional & Commercial Services | 66.2% | US$82.45M | -0.2x | 0 | US$2.03 | 6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alterity Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 57.1% | US$32.70M | -2.5x | -0.13 | US$3.77 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pinetree Capital | OTC Markets | Financial | Investment Banking & Investment Services | 39.7% | US$96.69M | 4.2x | 0.01 | US$9.78 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Entrepreneur Universe Bright Group | OTC Markets | Consumer Cyclicals | Media & Publishing | 36% | US$578.40M | 307.3x | 25.42 | US$0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cavitation Techs Inc | OTC Markets | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | 35% | US$7.80M | 6.7x | 0.05 | US$0.03 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Saddle Ranch Media | OTC Markets | Consumer Cyclicals | Media & Publishing | 33.3% | US$2.82M | -1.4x | 1.96 | US$0.0002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LandBridge Co LLC | NYSE | Energy | Oil & Gas | 31.9% | US$1.79B | 310.5x | US$77.05 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.7% Downside | Upgrade to Pro+ | ||
Wheaton Precious Metals | NYSE | Basic Materials | Metals & Mining | 30.9% | US$34.03B | 64x | -36.34 | US$75 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
CorMedix | NASDAQ | Healthcare | Pharmaceuticals | 29.6% | US$661.99M | -13.7x | -2.48 | US$10.91 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Equillium | NASDAQ | Healthcare | Biotechnology & Medical Research | 29.3% | US$27.39M | -6x | -0.13 | US$0.77 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cannabis Bioscience International Holdings | OTC Markets | Healthcare | Biotechnology & Medical Research | 23.1% | US$8.41M | -13.5x | -0.35 | US$0.0008 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LGL Group | NYSE Amex | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | 22.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||||||
Anterix | NASDAQ | Technology | Telecommunications Services | 21.4% | US$702.58M | -23.5x | 0.08 | US$37.80 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Catheter Precision | NYSE | Healthcare | Healthcare Equipment & Supplies | 21% | US$3.36M | -0x | -0 | US$0.42 | 12.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Delcath Systems | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 19.9% | US$458.29M | -14.7x | -0.25 | US$13.72 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Metalla Royalty & Streaming | NYSE | Basic Materials | Metals & Mining | 18.7% | US$282.95M | -40.5x | -0.78 | US$2.98 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Peakstone Realty Trust | NYSE | Real Estate | Residential & Commercial REITs | 18.7% | US$484.44M | -37.5x | -0.47 | US$13.18 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.4% Downside | Upgrade to Pro+ | |
Royal Gold | NASDAQ | Basic Materials | Metals & Mining | 18.4% | US$10.32B | 30.8x | 0.8 | US$157.01 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.4% Upside | Upgrade to Pro+ | |
Dynex Capital | NYSE | Real Estate | Residential & Commercial REITs | 16.4% | US$1.27B | 9.3x | 0.02 | US$14.04 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.2% Downside | Upgrade to Pro+ | |
BioRestorative Therapies | NASDAQ | Healthcare | Biotechnology & Medical Research | 15.8% | US$12.18M | -1.3x | -0.05 | US$1.76 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Authid | NASDAQ | Technology | Software & IT Services | 15.3% | US$80.60M | -5.3x | -0.1 | US$7.38 | 17.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clearside Biomedical | NASDAQ | Healthcare | Biotechnology & Medical Research | 14.2% | US$76.22M | -2.2x | -0.09 | US$1 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DeFi Tech | OTC Markets | Technology | Financial Technology (Fintech) & Infrastructure | 14.2% | US$959.72M | 11x | 0.06 | US$3.13 | 6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Trinity Capital | NASDAQ | Financial | Investment Banking & Investment Services | 14.1% | US$1.01B | 7.4x | US$16.14 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ATIF Holdings | NASDAQ | Industrials | Professional & Commercial Services | 13.9% | US$18.36M | -2.8x | -0.21 | US$1.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Global Net Lease | NYSE | Real Estate | Residential & Commercial REITs | 13.4% | US$1.80B | -10.3x | -0.19 | US$7.83 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.9% Upside | Upgrade to Pro+ | |
AGNC Invest | NASDAQ | Real Estate | Residential & Commercial REITs | 11.6% | US$9.16B | 10.9x | 0.01 | US$10.17 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
Sitio Royalties | NYSE | Energy | Oil & Gas | 11.6% | US$1.58B | 40.8x | 0.12 | US$20.28 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.1% Upside | Upgrade to Pro+ | |
VICI Properties | NYSE | Real Estate | Residential & Commercial REITs | 10.3% | US$33.31B | 12.4x | 3.44 | US$31.53 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11% Upside | Upgrade to Pro+ | |
Postal Realty | NYSE | Real Estate | Residential & Commercial REITs | 9.9% | US$326.63M | 64.7x | 0.82 | US$13.85 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
Strawberry Fields Reit | NYSE | Real Estate | Residential & Commercial REITs | 9.2% | US$139.89M | 21.2x | 0.73 | US$11.45 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.3% Upside | Upgrade to Pro+ | |
Inuvo | NYSE Amex | Technology | Software & IT Services | 9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||||||
Capital Southwest | NASDAQ | Financial | Investment Banking & Investment Services | 8.6% | US$1.13B | 15.6x | US$22.30 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Agree Realty | NYSE | Real Estate | Residential & Commercial REITs | 8.5% | US$8.08B | 42.3x | 9.47 | US$75.47 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.7% Upside | Upgrade to Pro+ | |
Phenixfin | NASDAQ | Financial | Collective Investments | 8.1% | US$107.72M | 6.5x | US$53.33 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Eterna Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 7.8% | US$13.82M | -0.1x | -0.02 | US$0.26 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
National Health Investors | NYSE | Real Estate | Residential & Commercial REITs | 7.6% | US$3.35B | 23.7x | US$73.34 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.3% Upside | Upgrade to Pro+ | ||
Evofem Biosciences | OTC Markets | Healthcare | Pharmaceuticals | 7.5% | US$1.13M | -0.1x | 0 | US$0.010 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Netstreit | NYSE | Real Estate | Residential & Commercial REITs | 7.4% | US$1.23B | -97.4x | 0.42 | US$15.02 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
LXP Industrial Trust | NYSE | Real Estate | Residential & Commercial REITs | 7.2% | US$2.58B | 67.4x | 1.15 | US$8.73 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26% Upside | Upgrade to Pro+ | |
Manhattan Bridge | NASDAQ | Real Estate | Residential & Commercial REITs | 7.2% | US$64.51M | 11.7x | 4.86 | US$5.64 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gaming & Leisure Properties | NASDAQ | Real Estate | Residential & Commercial REITs | 7.1% | US$13.80B | 17.5x | 5 | US$50.20 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.6% Upside | Upgrade to Pro+ | |
Caretrust Inc | NYSE | Real Estate | Residential & Commercial REITs | 6.4% | US$5.37B | 35.8x | 0.72 | US$28.64 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
Nexpoint Real Estate Finance | NYSE | Real Estate | Residential & Commercial REITs | 4.9% | US$276.41M | 12.4x | 0.03 | US$23.90 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AGNC Invest ADR | NASDAQ | Real Estate | Residential & Commercial REITs | 4.6% | US$9.16B | 10.9x | 0.01 | US$26.28 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Longeveron LLC | NASDAQ | Healthcare | Biotechnology & Medical Research | 4.5% | US$27.62M | -0.7x | -0.02 | US$1.85 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |